Product Name: Human CCR5 Antibody (Leronlimab, Research Use)
Catalog Number: NBR-0462
Target Name: CCR5
Trade Name: Leronlimab
Antibody Drug Description: Leronlimab, a monoclonal antibody investigational drug under development by CytoDyn, Inc. (CytoDyn), is one of the potential medicines that has been studied to determine whether it is safe and effective in treating patients with COVID-19, including those with severe outcomes from COVID-19. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CCR5
Synonyms: CC-CKR-5; CD195; CKR-5; CKR5; CMKBR5; IDDM22
Target Description: Receptor for a number of inflammatory CC-chemokines including CCL3/MIP-1-alpha, CCL4/MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level. May play a role in the control of granulocytic lineage proliferation or differentiation.
Ensembl: ENSG00000160791
Uniprot: P51681